Jennifer D Bilyeu - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Clinical Imaging|August 22, 2006

Intravenous lipoleiomyomatosisSamuel Paul Bilyeu, Jennifer D Bilyeu, Ranganathan Parthasarathy

Molecular Pharmacology|March 27, 2004

Circumvention of nuclear factor kappaB-induced chemoresistance by cytoplasmic-targeted anthracyclinesJennifer D Bilyeu, Ganesh R Panta, Lakita G Cavin, et al.

Oncogene|January 25, 2003

Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formationMarcello Arsura, Ganesh R Panta, Jennifer D Bilyeu, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Clinical Imaging|August 22, 2006

Intravenous lipoleiomyomatosisSamuel Paul Bilyeu, Jennifer D Bilyeu, Ranganathan Parthasarathy

Molecular Pharmacology|March 27, 2004

Circumvention of nuclear factor kappaB-induced chemoresistance by cytoplasmic-targeted anthracyclinesJennifer D Bilyeu, Ganesh R Panta, Lakita G Cavin, et al.

Oncogene|January 25, 2003

Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formationMarcello Arsura, Ganesh R Panta, Jennifer D Bilyeu, et al.

Pageof 1